Jaime Alexander, MD
Dermatology · Skokie, ILNPI 1104243070
Payments from drug & device makers
Across 93 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- Sanofi$250
- Johnson & Johnson$170
- Dermavant Sciences, Inc.$151
- Arcutis Biotherapeutics, Inc.$113
- Regeneron Healthcare Solutions, Inc.$111
- plus $712 from 14 others
What the payments were for
- Food & beverage$1,69793%
- Education$1317%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $322 |
| Sanofi | 11 | $250 |
| Johnson & Johnson | 4 | $170 |
| Dermavant Sciences, Inc. | 9 | $151 |
| Arcutis Biotherapeutics, Inc. | 6 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Amgen | 5 | $86 |
| Novartis | 4 | $80 |
| UCB, Inc. | 2 | $77 |
| Verrica Pharmaceuticals Inc. | 2 | $56 |
| Lilly USA, LLC | 3 | $56 |
| LEO Pharma Inc. | 3 | $54 |
| Galderma Laboratories, L.p. | 3 | $52 |
| Mayne Pharma Commercial LLC | 11 | $48 |
| Pfizer | 3 | $47 |
| Sun Pharmaceutical Industries Inc. | 2 | $47 |
| Biofrontera Inc. | 2 | $38 |
| Incyte Corporation | 1 | $29 |
| Organon | 2 | $27 |
| Journey Medical Corporation | 1 | $14 |
How this compares
$1,828 in reported general payments places this provider in the 45th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 197 | $2,513 |
| Tacrolimus | 19 | $1,691 |
| Clobetasol Propionate | 43 | $912 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 13 | $788 |
| Metronidazole | 18 | $743 |
| Triamcinolone Acetonide | 73 | $658 |
| Clindamycin Phosphate | 21 | $517 |
| Fluocinolone Acetonide | 13 | $418 |
| Hydrocortisone | 46 | $236 |
| Mupirocin | 31 | $201 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Skokie
- Stephanie MehlisSkokie$6.4M
- Shannon EwingSkokie$211K
- Nisha DesaiSkokie$151K
- Michael BukhaloRolling Meadows$6.8M
- Ahmad AminNaperville$4.6M
- George LewittNorthbrook$4M
- Raj ChovatiyaChicago$3.7M
- Peter LioChicago$2.5M
- Paul GetzWest Dundee$2.4M
- Kyle AmberBerwyn$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.